Tang Yi-Da, Kuzman James A, Said Suleman, Anderson Brent E, Wang Xuejun, Gerdes A Martin
Cardiovascular Research Institute, South Dakota Health Research Foundation, University of South Dakota School of Medicine, Sioux Valley Hospitals and Health Systems, Sioux Falls, SD, USA.
Circulation. 2005 Nov 15;112(20):3122-30. doi: 10.1161/CIRCULATIONAHA.105.572883. Epub 2005 Nov 7.
Although thyroid dysfunction has been linked to heart failure, it is not clear whether hypothyroidism alone can cause heart failure.
Hypothyroidism was induced in adult rats by treatment with 0.025% propylthiouracil (PTU) for 6 weeks (PTU-S) and 1 year (PTU-L). Echocardiographic measurements, left ventricular (LV) hemodynamics, isolated myocyte length (KOH method), myocardial blood flow (fluorescent microspheres), arteriolar morphometry, and gene expression (Western blot) were determined. Heart weight, heart rate, LV systolic blood pressure, LV ejection fraction, LV fractional shortening, and systolic wall thickness were reduced in PTU-S and PTU-L rats. LV internal diameter in systole increased by 40% in PTU-S and 86% in PTU-L. LV internal dimension in diastole was increased in PTU-S and PTU-L rats, but only PTU-L rats showed a significant increase in myocyte length due to series sarcomere addition. Resting and maximum (adenosine) myocardial blood flow were reduced in both PTU-S and PTU-L rats. Impaired blood flow was due to a large reduction in arteriolar length density and small arterioles in PTU-S and PTU-L (P<0.05 or greater for all of the above comparisons). Expression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)-2a and alpha-myosin heavy chain were reduced in hypothyroidism, whereas phospholamban and beta-myosin heavy chain were increased.
Hypothyroidism led to severe, progressive systolic dysfunction and increased chamber diameter/wall thickness ratio despite a reduction in cardiac mass. Chamber dilatation in PTU-L rats was due to series sarcomere addition, typical of heart failure. Hypothyroidism resulted in impaired myocardial blood flow due to a dramatic loss of arterioles. Thus, we have identified 2 important new mechanisms by which low thyroid function may lead to heart failure.
尽管甲状腺功能障碍与心力衰竭有关,但尚不清楚单纯甲状腺功能减退是否会导致心力衰竭。
用0.025%丙硫氧嘧啶(PTU)对成年大鼠进行治疗6周(PTU-S组)和1年(PTU-L组)以诱导甲状腺功能减退。测定超声心动图参数、左心室(LV)血流动力学、分离心肌细胞长度(KOH法)、心肌血流量(荧光微球法)、小动脉形态计量学及基因表达(蛋白质免疫印迹法)。PTU-S组和PTU-L组大鼠的心脏重量、心率、左心室收缩压、左心室射血分数、左心室缩短分数及收缩期室壁厚度均降低。PTU-S组大鼠左心室收缩期内径增加40%,PTU-L组增加86%。PTU-S组和PTU-L组大鼠左心室舒张期内径均增加,但只有PTU-L组大鼠因串联肌节增加导致心肌细胞长度显著增加。PTU-S组和PTU-L组大鼠静息和最大(腺苷)心肌血流量均降低。血流量受损是由于PTU-S组和PTU-L组小动脉长度密度和小动脉大量减少所致(上述所有比较P<0.05或更低)。甲状腺功能减退时,肌浆网/内质网Ca2+-ATP酶(SERCA)-2a和α-肌球蛋白重链表达降低,而受磷蛋白和β-肌球蛋白重链表达增加。
甲状腺功能减退导致严重的进行性收缩功能障碍,尽管心脏重量减轻,但心腔直径/室壁厚度比值增加。PTU-L组大鼠的心腔扩张是由于串联肌节增加,这是心力衰竭的典型表现。甲状腺功能减退导致小动脉大量丧失,进而引起心肌血流量受损。因此,我们确定了甲状腺功能低下可能导致心力衰竭的两个重要新机制。